Abstract
Article history: Received 26 November 2015 Accepted 12 December 2015 Available online 17 December 2015 ative effects, will have to be addressed [3]. Aside from the strategies of progenitor transplantation for ischemic cardiovascular diseases, approaches to improve endogenous EPC function by pharmacotherapy or non-pharmacotherapy may be alternative ways for therapeutic angiogenesis, as Dr. Guo et al. suggested [1]. Indeed, it has been demonstrated that endogenous EPC levels and func-
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
